01 9Emgality
02 1Emgality/Rayvow
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2020 Revenue in Millions : 363
2019 Revenue in Millions : 163
Growth (%) : 123
Main Therapeutic Indication : Neurology
Currency : USD
2021 Revenue in Millions : 577
2020 Revenue in Millions : 363
Growth (%) : 59
Main Therapeutic Indication : Neurology
Currency : USD
2022 Revenue in Millions : 651
2021 Revenue in Millions : 577
Growth (%) : 13
Main Therapeutic Indication : Neurology
Currency : USD
2022 Revenue in Millions : 45
2021 Revenue in Millions : 39
Growth (%) : 17
Main Therapeutic Indication : Neurology
Currency : USD
2023 Revenue in Millions : 678
2022 Revenue in Millions : 651
Growth (%) : 4
Main Therapeutic Indication : Neurology
Currency : USD
2023 Revenue in Millions : 49
2022 Revenue in Millions : 45
Growth (%) : 22
Main Therapeutic Indication : Neurology
Currency : USD
2024 Revenue in Millions : 870
2023 Revenue in Millions : 678
Growth (%) : 28
Main Therapeutic Indication : Neurology
Currency : USD
2024 Revenue in Millions : 13
2023 Revenue in Millions : 48
Growth (%) : -73
Main Therapeutic Indication : Neurology
Currency : USD
2024 Revenue in Millions : 107
2023 Revenue in Millions : 0
Growth (%) : NA
Main Therapeutic Indication : CNS & Anesthesia
Currency : USD
2019 Revenue in Millions : 163
2018 Revenue in Millions : 5
Growth (%) : 3,216
